Literature DB >> 14679125

The impact of sentinel node biopsy and axillary staging strategy on hospital costs.

R Rönkä1, K v Smitten, H Sintonen, T Kotomäki, L Krogerus, E Leppänen, M Leidenius.   

Abstract

BACKGROUND: The aim of the study was to evaluate total hospital costs of three different sentinel node biopsy (SNB) protocols compared to those of diagnostic axillary lymph node dissection (ALND). PATIENTS AND METHODS: The study included 237 consecutive breast cancer patients who underwent SNB with frozen section diagnosis. The sequence of the treatment procedures for each patient was recorded. The sequences of treatment procedures for the same patients were evaluated using three hypothetical scenarios: diagnostic ALND, SNB without frozen section diagnosis and SNB as day case surgery prior to the breast operation. The total hospital costs were calculated in all protocols.
RESULTS: The hospital costs per patient were 3750euro;. The hospital costs per patient would have been 3020euro; when using the ALND model, 4087euro; had the frozen section not been applied and 4573euro; using 'SNB as day case surgery' model. The costs with or without frozen section diagnosis would have been equal with a threshold false negative rate of 35%.
CONCLUSIONS: SNB seems to be associated with higher hospital costs than diagnostic ALND. Frozen section diagnosis seems to be worthwhile as long as the false negative rate is <35%.

Entities:  

Mesh:

Year:  2004        PMID: 14679125     DOI: 10.1093/annonc/mdh019

Source DB:  PubMed          Journal:  Ann Oncol        ISSN: 0923-7534            Impact factor:   32.976


  7 in total

Review 1.  Recent progress in the treatment and prevention of cancer-related lymphedema.

Authors:  Simona F Shaitelman; Kate D Cromwell; John C Rasmussen; Nicole L Stout; Jane M Armer; Bonnie B Lasinski; Janice N Cormier
Journal:  CA Cancer J Clin       Date:  2014-11-19       Impact factor: 508.702

2.  Cost comparison of axillary sentinel lymph node detection and axillary lymphadenectomy in early breast cancer. A national study based on a prospective multi-institutional series of 985 patients 'on behalf of the Group of Surgeons from the French Unicancer Federation'.

Authors:  J M Classe; S Baffert; B Sigal-Zafrani; M Fall; C Rousseau; S Alran; P Rouanet; C Belichard; H Mignotte; G Ferron; F Marchal; S Giard; C Tunon de Lara; G Le Bouedec; J Cuisenier; R Werner; I Raoust; J-F Rodier; F Laki; P-E Colombo; S Lasry; C Faure; H Charitansky; J-B Olivier; M-P Chauvet; E Bussières; P Gimbergues; B Flipo; G Houvenaeghel; F Dravet; A Livartowski
Journal:  Ann Oncol       Date:  2011-09-06       Impact factor: 32.976

3.  The pen and the scalpel: effect of diffusion of information on nonclinical variations in surgical treatment.

Authors:  Jennifer J Griggs; Melony E S Sorbero; Gretchen M Ahrendt; Azadeh Stark; Susanne Heininger; Heather T Gold; Linda M Schiffhauer; Andrew W Dick
Journal:  Med Care       Date:  2009-07       Impact factor: 2.983

4.  Sentinel lymph node biopsy revisited: ultrasound-guided photoacoustic detection of micrometastases using molecularly targeted plasmonic nanosensors.

Authors:  Geoffrey P Luke; Jeffrey N Myers; Stanislav Y Emelianov; Konstantin V Sokolov
Journal:  Cancer Res       Date:  2014-08-08       Impact factor: 12.701

5.  Ultrasound-guided photoacoustic imaging for the selective detection of EGFR-expressing breast cancer and lymph node metastases.

Authors:  Meihua Zhang; Hoe Suk Kim; Tiefeng Jin; Ann Yi; Woo Kyung Moon
Journal:  Biomed Opt Express       Date:  2016-04-19       Impact factor: 3.732

6.  The Role of Surgical Axillary Staging Prior to Immediate Breast Reconstruction in the Era of De-Escalation of Axillary Management in Early Breast Cancer.

Authors:  Miriam Svensson; Looket Dihge
Journal:  J Pers Med       Date:  2022-08-04

7.  Evaluation of the benefit of routine intraoperative frozen section analysis of sentinel lymph nodes in breast cancer.

Authors:  C M T P Francissen; R F D van la Parra; A H Mulder; A M Bosch; W K de Roos
Journal:  ISRN Oncol       Date:  2013-09-16
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.